Position history for MORGAN STANLEY's holdings in TAYSHA GENE THERAPIES INC
MORGAN STANLEY holds 18M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $80.3M as of 2026-Q1. The position was decreased (-0.6% shares). TSHA represents 0.0% of MORGAN STANLEY's portfolio.
Current Value
$80.3M
Current Shares
18M
Total Value Change
+$63.6M
Total Shares Change
+10.5M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc.
Decreased |
| 18M |
-0.6% |
| $80.3M |
| 0.0% |
| $4.53 |
0 |
| 2025-Q4 | Decreased | 18.1M | -6.4% | $99.4M | 0.0% | $5.66 | 0 |
| 2025-Q3 | Increased | 19.3M | +14.5% | $63.1M | 0.0% | $3.16 | 34 |
| 2025-Q2 | Increased | 16.9M | +0.1% | $39M | 0.0% | $2.38 | 29 |
| 2025-Q1 | Decreased | 16.8M | -4.5% | $23.4M | 0.0% | $1.93 | 0 |
| 2024-Q4 | Increased | 17.6M | +130.2% | $30.5M | 0.0% | $1.73 | 46 |
| 2024-Q3 | Increased | 7.7M | +2.5% | $15.4M | 0.0% | $2.07 | 29 |
| 2024-Q2 | New | 7.5M | - | $16.7M | 0.0% | $2.24 | 39 |